Pharmaniaga turns in lower earnings


Lodin: ‘Moving forward, the healthcare sector continues to offer good prospects, both in Malaysia and in international markets.’ – Bernama

PETALING JAYA: Pharmaniaga Bhd’s earnings fell 45.7% to RM45.6mil in the financial year ended Dec 31, 2016 as it was impacted by higher operating expenses and finance costs.

The pharmaceutical company said the earnings fell from RM84.04mil in financial year 2015 (FY15).

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

   

Next In Business News

Wall St set to open slightly higher, extend weekly gains
ACE Market-listed Pappajack seeks to transfer listing to Main Market
GIIB affirms financial statements integrity amid former director's forgery charges
Ringgit retreats against US dollar at the close on profit-taking
Mokhzani Mahathir is stepping down as chairman of Maxis
Malayan Flour Mills earmarks RM300mil capex for FY24
Epicon gets subcontract job worth RM50mil
Kawan Renergy IPO oversubscribed by 94.99 times
FBM KLCI extends gain to fresh 26-month high
Top HSBC shareholder Ping An will retain investment in bank, source says, amid sale talk

Others Also Read